ReviewFrontiers in public health2026
Artificial intelligence and the future of maternal and newborn health in low-income countries: advancing equity, early detection, and health system resilience.
Review in Frontiers in public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Maternal and newborn mortality remain major public health challenges in low-income countries, where poverty, health workforce shortages, limited access to quality care, and weak health systems contribute to preventable deaths and adverse outcomes. Artificial intelligence (AI) has emerged as a promising tool for strengthening maternal and newborn health through improved risk prediction, early diagnosis, clinical decision support, and health system planning. This narrative review examines the potential of AI to advance equity, enhance early detection of complications, and improve health system resilience in resource-constrained settings. Evidence suggests that AI applications can support the identification of high-risk pregnancies, improve the early detection of conditions such as preeclampsia, neonatal sepsis, and respiratory disorders, expand access to obstetric ultrasound services, and optimize resource allocation. AI-enabled digital health platforms also have the potential to strengthen community outreach, referral systems, and quality improvement initiatives across the continuum of maternal and newborn care. However, significant challenges remain, including inadequate digital infrastructure, limited technical capacity, poor data quality, algorithmic bias, and weak regulatory frameworks. The review concludes that AI can contribute meaningfully to reducing maternal and neonatal morbidity and mortality when integrated within broader health system strengthening efforts. Strategic investments in governance, workforce development, digital infrastructure, and equity-focused implementation are essential to ensure that AI technologies support sustainable and inclusive improvements in maternal and newborn health outcomes.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.